Expression and prognosis of GNG5 in lower-grade glioma using public database

References

• Anderson NM, Simon MC. 2020. The tumor microenvironment. Current Biol: CB. 30:R921–r925. doi:10.1016/j.cub.2020.06.081.
   PubMed Web of Science ®Google Scholar
• Barrett T, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Holko M, et al. 2013. NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 41:D991–D995. doi:10.1093/nar/gks1193.
   PubMed Web of Science ®Google Scholar
• Bozic T, Lin Q, Frobel J, Wilop S, Hoffmann M, Muller-Tidow C, Brummendorf TH, Jost E, Wagner W. 2015. DNA-methylation in C1R is a prognostic biomarker for acute myeloid leukemia. Clin Epigenetics. 7:116. doi:10.1186/s13148-015-0153-6.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research, N., Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, et al. 2015. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 372:2481–2498. doi:10.1056/NEJMoa1402121.
   PubMed Web of Science ®Google Scholar
• Cejalvo T, Gargini R, Segura-Collar B, Mata-Martinez P, Herranz B, Cantero D, Ruano Y, Garcia-Perez D, Perez-Nunez A, Ramos A, et al. 2020. Immune profiling of gliomas reveals a connection with IDH1/2 mutations. Tau Function and the Vascular Phenotype. Cancers (Basel). 12. doi:10.3390/cancers12113230.
   Google Scholar
• Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S. 2017. UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia (New York, N.Y.). 19:649–658. doi:10.1016/j.neo.2017.05.002.
   PubMed Web of Science ®Google Scholar
• Chen LH, Liu JF, Lu Y, He XY, Zhang C, Zhou HH. 2021. Complement C1q (C1qA, C1qB, and C1qC) May Be a potential prognostic factor and an index of tumor microenvironment remodeling in osteosarcoma. Front Oncol. 11:642144. doi:10.3389/fonc.2021.642144.
   PubMed Web of Science ®Google Scholar
• Chen X, Yan Y, Zhou J, Huo L, Qian L, Zeng S, Li Z, Wei J, Xu Z, Gong Z. 2019. Clinical prognostic value of isocitrate dehydrogenase mutation, O-6-methylguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in glioma patients. Ann Transl Med. 7:541. doi:10.21037/atm.2019.09.126.
   PubMed Web of Science ®Google Scholar
• Chen YH, Hueng DY, Tsai WC. 2018. Proteolipid protein 2 overexpression indicates aggressive tumor behavior and adverse prognosis in human gliomas. Int J Mol Sci. 19. doi:10.3390/ijms19113353.
   Web of Science ®Google Scholar
• Cheng CW, Chang CC, Patria YN, Chang RT, Liu YR, Li FA, Shih HM, Lin CY. 2018. Sex hormone-binding globulin (SHBG) is a potential early diagnostic biomarker for gastric cancer. Cancer Med. 7:64–74. doi:10.1002/cam4.1254.
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Killingsworth MC, Myasoedova VA, Orekhov AN, Bobryshev YV. 2017. CD68/macrosialin: not just a histochemical marker. Lab Invest. 97:4–13. doi:10.1038/labinvest.2016.116.
   PubMed Web of Science ®Google Scholar
• Claus EB, Walsh KM, Wiencke JK, Molinaro AM, Wiemels JL, Schildkraut JM, Bondy ML, Berger M, Jenkins R, Wrensch M. 2015. Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus. 38:E6. doi:10.3171/2014.10.FOCUS12367.
   PubMed Web of Science ®Google Scholar
• Dabrowski MJ, Draminski M, Diamanti K, Stepniak K, Mozolewska MA, Teisseyre P, Koronacki J, Komorowski J, Kaminska B, Wojtas B. 2018. Unveiling new interdependencies between significant DNA methylation sites, gene expression profiles and glioma patients survival. Sci Rep. 8:4390. doi:10.1038/s41598-018-22829-1.
   PubMed Web of Science ®Google Scholar
• Dave VP. 2011. Role of CD3epsilon-mediated signaling in T-cell development and function. Crit Rev Immunol. 31:73–84. doi:10.1615/critrevimmunol.v31.i1.70.
   PubMed Web of Science ®Google Scholar
• Du JX, Chen C, Luo YH, Cai JL, Cai CZ, Xu J, Ni XJ, Zhu W. 2020. Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer. Gene. 762:144974. doi:10.1016/j.gene.2020.144974.
   PubMed Web of Science ®Google Scholar
• Geng RX, Li N, Xu Y, Liu JH, Yuan FE, Sun Q, Liu BH, Chen QX. 2018. Identification of core biomarkers associated with outcome in glioma: evidence from bioinformatics analysis. Dis Markers. 2018:3215958. doi:10.1155/2018/3215958.
   PubMed Web of Science ®Google Scholar
• Harari A, Graciotti M, Bassani-Sternberg M, Kandalaft LE. 2020. Antitumour dendritic cell vaccination in a priming and boosting approach. Nat Rev Drug Discov. 19:635–652. doi:10.1038/s41573-020-0074-8.
   PubMed Web of Science ®Google Scholar
• Hong X, Nelson KK, deCarvalho AC, Kalkanis SN. 2010. Heparanase expression of glioma in human and animal models. J Neurosurg. 113:261–269. doi:10.3171/2009.9.Jns09682.
   PubMed Web of Science ®Google Scholar
• Huang L, Li X, Ye H, Liu Y, Liang X, Yang C, Hua L, Yan Z, Zhang X. 2020. Long non-coding RNA NCK1-AS1 promotes the tumorigenesis of glioma through sponging microRNA-138-2-3p and activating the TRIM24/Wnt/beta-catenin axis. J Exp Clin Cancer Res. 39:63. doi:10.1186/s13046-020-01567-1.
   PubMed Web of Science ®Google Scholar
• Iqbal AJ, Krautter F, Blacksell IA, Wright RD, Austin-Williams SN, Voisin MB, Hussain MT, Law HL, Niki T, Hirashima M, et al. 2022. Galectin-9 mediates neutrophil capture and adhesion in a CD44 and β2 integrin-dependent manner. FASEB J. 36:e22065. doi:10.1096/fj.202100832R.
   PubMed Web of Science ®Google Scholar
• Jiang J, Ding Y, Wu M, Lyu X, Wang H, Chen Y, Wang H, Teng L. 2020. Identification of TYROBP and C1QB as Two novel Key genes With prognostic value in gastric cancer by network analysis. Front Oncol. 10:1765. doi:10.3389/fonc.2020.01765.
   PubMedGoogle Scholar
• Kerschner-Morales SL, Kuhne M, Becker S, Beck JF, Sonnemann J. 2020. Anticancer effects of the PLK4 inhibitors CFI-400945 and centrinone in ewing's sarcoma cells. J Cancer Res Clin Oncol. 146:2871–2883. doi:10.1007/s00432-020-03346-z.
   PubMed Web of Science ®Google Scholar
• Li G, Wang Z, Zhang C, Liu X, Yang F, Sun L, Liang J, Hu H, Liu Y, You G, et al. 2018. MEGF10, a glioma survival-associated molecular signature, predicts IDH mutation status. Dis Markers. 2018:5975216. doi:10.1155/2018/5975216.
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, Li B, Liu XS. 2020. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48:W509–w514. doi:10.1093/nar/gkaa407.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang Q, Chen G, Luo D. 2021. Multi-Omics analysis showed the clinical value of gene signatures of C1QC(+) and SPP1(+) TAMs in cervical cancer. Front Immunol. 12:694801. doi:10.3389/fimmu.2021.694801.
   PubMed Web of Science ®Google Scholar
• Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS. 2018. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011-2015. Neuro Oncol. 20:iv1–iv86. doi:10.1093/neuonc/noy131.
   PubMed Web of Science ®Google Scholar
• Petitprez F, de Reynies A, Keung EZ, Chen TW, Sun CM, Calderaro J, Jeng YM, Hsiao LP, Lacroix L, Bougouin A, et al. 2020. B cells are associated with survival and immunotherapy response in sarcoma. Nature. 577:556–560. doi:10.1038/s41586-019-1906-8.
   PubMed Web of Science ®Google Scholar
• Qiu H, Tian W, He Y, Li J, He C, Li Y, Liu N, Li J. 2021. Integrated analysis reveals prognostic value and immune correlates of CD86 expression in lower grade glioma. Front Oncol. 11:654350. doi:10.3389/fonc.2021.654350.
   PubMed Web of Science ®Google Scholar
• Raden M, Mohamed MM, Ali SM, Backofen R. 2018. Interactive implementations of thermodynamics-based RNA structure and RNA-RNA interaction prediction approaches for example-driven teaching. PLoS Comput Biol. 14:e1006341. doi:10.1371/journal.pcbi.1006341.
   PubMedGoogle Scholar
• Sales TT, Resende FF, Chaves NL, Titze-De-Almeida SS, Bao SN, Brettas ML, Titze-De-Almeida R. 2016. Suppression of the Eag1 potassium channel sensitizes glioblastoma cells to injury caused by temozolomide. Oncol Lett. 12:2581–2589. doi:10.3892/ol.2016.4992.
   PubMed Web of Science ®Google Scholar
• Sepulveda JL. 2020. Using R and bioconductor in clinical genomics and transcriptomics. J Mole Diag. 22:3–20. doi:10.1016/j.jmoldx.2019.08.006.
   PubMed Web of Science ®Google Scholar
• Shi H, Song Y, Song Z, Huang C. 2021. CKMT1B is a potential prognostic biomarker and associated with immune infiltration in lower-grade glioma. PLoS One. 16:e0245524. doi:10.1371/journal.pone.0245524.
   PubMed Web of Science ®Google Scholar
• Singh R, Bhardwaj V, Das P, Purohit R. 2020. Natural analogues inhibiting selective cyclin-dependent kinase protein isoforms: a computational perspective. J Biomol Struct Dyn. 38:5126–5135. doi:10.1080/07391102.2019.1696709.
   PubMed Web of Science ®Google Scholar
• Singh R, Bhardwaj VK, Sharma J, Das P, Purohit R. 2021. Identification of selective cyclin-dependent kinase 2 inhibitor from the library of pyrrolone-fused benzosuberene compounds: an in silico exploration. J Biomol Struct Dyn. 1–9. doi:10.1080/07391102.2021.1900918.
   Web of Science ®Google Scholar
• Stupp R, Hegi ME, Gilbert MR, Chakravarti A. 2007. Chemoradiotherapy in malignant glioma: standard of care and future directions. J Clin Oncol. 25:4127–4136. doi:10.1200/JCO.2007.11.8554.
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 102:15545–15550. doi:10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Taher MM, Dairi G, Butt EM, Al-Quthami K, Al-Khalidi H, Jastania RA, Nageeti TH, Bogari NM, Athar M, Al-Allaf FA, et al. 2020. EGFRvIII expression and isocitrate dehydrogenase mutations in patients with glioma. Oncol Lett. 20:384. doi:10.3892/ol.2020.12247.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z. 2017. GEPIA: a web server for cancer and Normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45:W98–w102. doi:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Thul PJ, Lindskog C. 2018. The human protein atlas: A spatial map of the human proteome. Protein Sci. 27:233–244. doi:10.1002/pro.3307.
   PubMed Web of Science ®Google Scholar
• van den Bent MJ. 2010. Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective. Acta Neuropathol. 120:297–304. doi:10.1007/s00401-010-0725-7.
   PubMed Web of Science ®Google Scholar
• Vigneswaran K, Neill S, Hadjipanayis CG. 2015. Beyond the world health organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification. Ann Transl Med. 3:95. doi:10.3978/j.issn.2305-5839.2015.03.57.
   PubMed Web of Science ®Google Scholar
• Wang H, Li Y, Shi G, Wang Y, Lin Y, Wang Q, Zhang Y, Yang Q, Dai L, Cheng L, et al. 2020. A novel antitumor strategy: simultaneously inhibiting angiogenesis and complement by targeting VEGFA/PIGF and C3b/C4b. Mol Ther Oncolytics. 16:20–29. doi:10.1016/j.omto.2019.12.004.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jensen MA, Zenklusen JC. 2016. A practical guide to The cancer genome atlas (TCGA). Methods Mole Biol (Clifton, N.J.). 1418:111–141. doi:10.1007/978-1-4939-3578-9_6.
   PubMedGoogle Scholar
• Weller M, Wick W, Aldape K, Brada M, Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, et al. 2015. Glioma. Nat Rev Dis Primers. 1:15017. doi:10.1038/nrdp.2015.17.
   PubMed Web of Science ®Google Scholar
• Xi S, Zhang X, Chen H, Zhong Z, Lu J, Hu W, Wu Q, Zeng J. 2015. Downregulation of ring-finger protein 43 in glioma associates with poor prognosis. Int J Clin Exp Pathol. 8:490–496.
   PubMed Web of Science ®Google Scholar
• Xiao K, Liu Q, Peng G, Su J, Qin CY, Wang XY. 2020. Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma. PeerJ. 8:e8312. doi:10.7717/peerj.8312.
   PubMed Web of Science ®Google Scholar
• Xu J, Dai S, Yuan Y, Xiao Q, Ding K. 2020. A prognostic model for colon cancer patients based on eight signature autophagy genes. Front Cell Dev Biol. 8:602174. doi:10.3389/fcell.2020.602174.
   PubMed Web of Science ®Google Scholar
• Xu S, Tang L, Liu Z, Luo C, Cheng Q. 2021. Hypoxia-Related lncRNA correlates With prognosis and immune microenvironment in lower-grade glioma. Front Immunol. 12:731048. doi:10.3389/fimmu.2021.731048.
   PubMed Web of Science ®Google Scholar
• Xue L, Liu H, Chen Y, Wei L, Hong J. 2020. Computational analysis and verification of molecular genetic targets for glioblastoma. Biosci Rep. 40. doi:10.1042/BSR20201401.
   Web of Science ®Google Scholar
• Yajima I, Kumasaka MY, Yamanoshita O, Zou C, Li X, Ohgami N, Kato M. 2014. GNG2 inhibits invasion of human malignant melanoma cells with decreased FAK activity. Am J Cancer Res. 4:182–188.
   PubMed Web of Science ®Google Scholar
• Yang B, Han ZY, Wang WJ, Ma YB, Chu SH. 2020. GNG5 is an unfavourable independent prognostic indicator of gliomas. J Cell Mol Med. 24:12873–12878. doi:10.1111/jcmm.15923.
   PubMed Web of Science ®Google Scholar
• Yuan K, Ye J, Liu Z, Ren Y, He W, Xu J, He Y, Yuan Y. 2020. Complement C3 overexpression activates JAK2/STAT3 pathway and correlates with gastric cancer progression. J Exp Clin Cancer Res. 39:9. doi:10.1186/s13046-019-1514-3.
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen Z, Wang Z, Dai Z, Hu Z, Zhang X, Hu M, Liu Z, Cheng Q. 2021. Correlation between APOBEC3B expression and clinical characterization in lower-grade gliomas. Front Oncol. 11:625838. doi:10.3389/fonc.2021.625838.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen M, Zhao Y, Xiong H, Sneh T, Fan Y, Wang J, Zhou X, Gong C. 2020. Complement and coagulation cascades pathway correlates with chemosensitivity and overall survival in patients with soft tissue sarcoma. Eur J Pharmacol. 879:173121. doi:10.1016/j.ejphar.2020.173121.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu M, Fang Y, Li J, Chen Y, Jiao S. 2022. TP53 r273c mutation Is associated With poor prognosis in LGG patients. Front Genet. 13:720651. doi:10.3389/fgene.2022.720651.
   PubMed Web of Science ®Google Scholar
• Zhang QW, Liu L, Gong CY, Shi HS, Zeng YH, Wang XZ, Zhao YW, Wei YQ. 2012. Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature. PLoS One. 7:e50946. doi:10.1371/journal.pone.0050946.
   PubMed Web of Science ®Google Scholar
• Zhao X, Liu Z, Ren Z, Wang H, Wang Z, Zhai J, Cao D, Lyu S, Li L, Lang R, et al. 2020. Triptolide inhibits pancreatic cancer cell proliferation and migration via down-regulating PLAU based on network pharmacology of tripterygium wilfordii hook F. Eur J Pharmacol. 880:173225. doi:10.1016/j.ejphar.2020.173225.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang KN, Wang Q, Li G, Zeng F, Zhang Y, Wu F, Chai R, Wang Z, Zhang C, et al. 2021. Chinese glioma genome atlas (CGGA): A comprehensive resource with functional genomic data from Chinese glioma patients. Genomics Proteomics Bioinformatics. 19:1–12. doi:10.1016/j.gpb.2020.10.005.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Yang L, Zhang X, Chen R, Chen X, Tang W, Zhang M. 2019. Identification of potential biomarkers in glioblastoma through bioinformatic analysis and evaluating their prognostic value. Biomed Res Int. 2019:6581576. doi:10.1155/2019/6581576.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. 2019. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 10:1523. doi:10.1038/s41467-019-09234-6.
   PubMed Web of Science ®Google Scholar